Uranium Royalty Corp.

$3.09 ▼ -13.45%
2026-06-06 11:13:00

Explore Uranium Royalty Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$530.48 M
Current Price
$3.09
52W High / Low
$7.5 / $3.02
Stock P/E
168.16
Book Value
$1.59
Dividend Yield
ROCE
-1.63%
ROE
1.35%
Face Value
EPS
$0.02
Exp Qtr EPS
Sector
Energy

UROY — Monthly Price History

Adjusted close price  ·  Hover to see price & month

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.
  • Strong operating margin profile.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Valuation is rich on a P/E basis.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Cameco Corporation $103.44 97.55 $32.9 B 0% 6.73% 9.47% $135.24 / $59.1 $11.41
2. NexGen Energy Ltd. $10.28 $7.56 B -4.88% -30.3% $18.91 / $8.5 $1
3. Uranium Energy Corp. $12.65 6,990,548,720 $6.38 B -6.79% -7.09% $20.34 / $5.9 $2.17
4. Energy Fuels Inc. $15.03 $4.5 B -7.33% -10.23% $27.9 / $5.24 $2.82
5. Centrus Energy Corp. $161.78 53.94 $3.27 B 2.48% 10.71% $464.25 / $130.81 $38.91
6. Denison Mines Corp. $3.03 $3.08 B -8.16% -73.67% $6.04 / $2.15 $0.29
7. Ur-Energy Inc. $1.62 $1.07 B -28.34% -105.1% $3.3 / $1.1 $0.2

Quarterly Results

Figures shown in M / B

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Sales16.66 M0.04 M33.21 M4.69 M0 M
Operating Profit2.93 M-3.22 M3.07 M-0.98 M-1.75 M
Net Profit1.96 M2.06 M1.52 M-1.16 M-1.91 M
EPS in Rs0.010.010.01-0.01-0.010

Profit & Loss

Figures shown in M / B

2025202420232022
Sales15.6 M42.71 M13.85 M0 M
Operating Profit-4.81 M7.08 M-3.78 M-5.49 M
Net Profit-5.65 M9.78 M-5.84 M-4.26 M
EPS in Rs-0.040.07-0.04-0.03

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets296.07 M278.7 M185.79 M178.17 M
Total Liabilities1.18 M2.91 M10.42 M13.54 M
Equity294.89 M275.79 M175.37 M164.64 M
Current Assets238.16 M231.75 M138.83 M134.03 M
Current Liabilities1.02 M2.76 M10.34 M0.49 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF-21.63 M-104.84 M-11.46 M-68.8 M
Investing CF-11.36 M45.23 M12.19 M-19.09 M
Financing CF24.39 M66.6 M9.2 M85.06 M
Free CF-33.21 M-104.92 M-13.63 M-82.56 M
Capex-11.58 M-0.07 M-2.17 M-13.75 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2024202320222021
Revenue Growth %208.26%
Earnings Growth %267.38%-37.26%
Profit Margin %22.9%-42.18%
Operating Margin %16.57%-27.3%
Gross Margin %34.55%20.35%
EBITDA Margin %18.24%-30.3%

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
GLOBAL X FUNDS-Global X Uranium ETF Mutual Fund 7.65 M $28.24 M 0.05% 2026-02-28
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund Mutual Fund 0.09 M $0.33 M 0% 2026-02-28
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF Mutual Fund 0.07 M $0.25 M 0% 2026-01-31
American Century ETF Trust-Avantis International Small Cap Equity ETF Mutual Fund 0.01 M $0.04 M 0% 2026-01-31
Mirae Asset Global ETFs Holdings Ltd. Institutional 7.92 M $29.22 M 0.05% 2025-12-31
CenterBook Partners LP Institutional 4.45 M $16.41 M 0.03% 2025-12-31
SPROTT FUNDS TRUST-SPROTT URANIUM MINERS ETF Mutual Fund 4.44 M $16.4 M 0.03% 2025-12-31
Alps Advisors Inc. Institutional 3.89 M $14.36 M 0.03% 2025-12-31
SPROTT FUNDS TRUST-Sprott Junior Uranium Miners ETF Mutual Fund 3.77 M $13.9 M 0.03% 2025-12-31
Morgan Stanley Institutional 3.36 M $12.4 M 0.02% 2025-12-31
Accordant Advisory Group Inc Institutional 2.47 M $9.12 M 0.02% 2025-12-31
Sprott Inc. Institutional 1.62 M $5.98 M 0.01% 2025-12-31
Vident Advisory, LLC Institutional 1.38 M $5.11 M 0.01% 2025-12-31
Simcoe Capital LLC Institutional 1.13 M $4.17 M 0.01% 2025-12-31
Jane Street Group, LLC Institutional 0.77 M $2.85 M 0.01% 2025-12-31

Frequently Asked Questions — Uranium Royalty Corp.

Will Uranium Royalty Corp. stock hit $4 in 2026?

Uranium Royalty Corp. (UROY) is currently trading at $3.09, with a 52-week range of $3.02 to $7.5. Reaching the $4 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $4.51 for Uranium Royalty Corp., with a Strong_buy rating, and the most bullish analysts see the stock reaching as high as $4.51. Whether Uranium Royalty Corp. can reach $4 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Energy space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, UROY has delivered a 3.5% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the UROY Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Uranium Royalty Corp. stock worth buying at $3.09?

Whether Uranium Royalty Corp. (UROY) is worth buying at $3.09 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Uranium Royalty Corp. trades at a Price-to-Earnings (P/E) ratio of 168.2x, which can be compared against other Energy companies to assess whether the stock is expensive or attractively priced relative to its peers.

Profitability & efficiency: Uranium Royalty Corp. has a Return on Capital Employed (ROCE) of -1.6%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at 1.4%.

Financial health: The Debt-to-Equity ratio of 0.04 indicates a conservative balance sheet with more equity than debt, reducing financial risk.

Analyst view: The Wall Street consensus recommendation for UROY is currently Strong_buy, with a mean price target of $4.51 based on 1 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Uranium Royalty Corp. (UROY) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $4.51 for Uranium Royalty Corp. (UROY), aggregated from 1 analyst ratings. The overall analyst recommendation is Strong_buy.

The price target range spans from $4.51 on the bearish end to $4.51 on the most optimistic projection, with a median target of $4.51. This wide range reflects differing views on Uranium Royalty Corp.'s growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the UROY analysis page on StockSifting.

Is Uranium Royalty Corp. overvalued at a P/E ratio of 168.2x?

Uranium Royalty Corp. (UROY) currently has a Price-to-Earnings (P/E) ratio of 168.2x, meaning investors are paying $168.2 for every $1 of the company's trailing twelve-month earnings. Whether this makes the stock overvalued depends on several contextual factors:

Sector context: The Energy sector tends to command higher valuation multiples when growth expectations are elevated. A 168.2x P/E is on the higher end, suggesting the market is pricing in continued strong earnings growth — any disappointment in future earnings could lead to a multiple contraction.

Growth-adjusted valuation: A P/E ratio in isolation can be misleading. Fast-growing companies often deserve higher P/E multiples because their future earnings are expected to rise significantly. A more complete picture comes from looking at the PEG ratio (P/E divided by earnings growth rate) — a PEG below 1 is often considered undervalued, while above 2 may signal overvaluation. Uranium Royalty Corp.'s ROCE of -1.6% suggests it has moderate capital returns.

Additional metrics to review: P/E is just one lens. Compare it alongside the Price-to-Book (P/B) ratio, EV/EBITDA, Price-to-Sales, and free cash flow yield for a more complete valuation picture. View all of UROY's valuation ratios on StockSifting's ratios section. Valuation is subjective and context-dependent — this is not investment advice.

What will Uranium Royalty Corp. stock be worth in 2029?

Projecting Uranium Royalty Corp. (UROY)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

Based on UROY's historical 5-year Compound Annual Growth Rate (CAGR) of 3.5%, if that rate of growth were to continue, the stock could reach approximately $3 by 2029 — up from its current price of $3.09. This projection assumes the historical CAGR holds, which depends on Uranium Royalty Corp. sustaining its revenue growth, maintaining profit margins, and the market continuing to reward it at a similar valuation multiple.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the UROY Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.